Public health
fromThe Atlantic
2 days agoAmerica Should Fear Polio
Polio vaccination in the U.S. faces reconsideration due to low disease risk, shifting HHS leadership, and heightened scrutiny of vaccines despite safety evidence.
The Trump administration's Department of Health and Human Services has reduced some vaccine access. The agency scaled back COVID-19 vaccine recommendations, approved COVID-19 vaccines for fewer people and aimed to remove the preservative thimerosal from U.S. vaccines. Experts told PolitiFact scientific research did not support its removal.